Search

everythinglearnresearchcommunity

for

Search:↓

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Lower LDL-c levels predict higher COVID-19 mortality.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hair loss link to severe COVID-19 unclear.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Testosterone's effects on COVID-19 are unclear and need more research.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.